Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.6% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
11
users have liked this narrative
3
users have commented on this narrative
45
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
23.7% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
0
users have commented on this narrative
17
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.3% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
2
users have commented on this narrative
17
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Zevia PBC
AN
AnalystHighTarget
Consensus Narrative from 6 Analysts
Clean Label Trends Will Drive Health Beverage Expansion
Key Takeaways Strong brand momentum and expansion into new channels position Zevia for accelerated growth and increased market share versus established competitors. Product innovation, clean ingredients, and favorable regulatory trends are expected to drive premium pricing and higher margins, surpassing current market expectations.
View narrative
US$6.00
FV
51.5% undervalued
intrinsic discount
7.31%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Valens Semiconductor
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
Electric Vehicles And IoT Will Drive High-Speed Chipset Adoption
Key Takeaways Valens's expanding OEM partnerships and industry endorsements suggest its technology could attain mass-market adoption, accelerating revenue and margin growth ahead of consensus expectations. Its strong technological differentiation, IP position, and financial flexibility provide durable competitive advantages, enabling entry into new markets and supporting predictable, high-quality recurring earnings.
View narrative
US$5.00
FV
57.8% undervalued
intrinsic discount
24.30%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
BlackSky Technology
AN
AnalystHighTarget
Consensus Narrative from 8 Analysts
Gen-3 And Arrow Constellations Will Capture Accelerating Secular Tailwinds
Key Takeaways Gen-3 satellite adoption and AI-driven platforms are accelerating revenue growth and margins beyond expectations, positioning BlackSky as a clear industry leader. Vertical integration, expanding global demand, and critical infrastructure status are driving strong backlog growth, operating leverage, and potential market dominance across key segments.
View narrative
US$31.00
FV
41.4% undervalued
intrinsic discount
30.90%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
2 days ago
author updated this narrative
REGENXBIO
AN
AnalystHighTarget
Consensus Narrative from 12 Analysts
Pipeline Launches And Demographic Trends Will Drive Broad Gene Adoption
Key Takeaways The company's advanced manufacturing and strong pipeline provide significant upside for margin expansion, rapid commercialization, and durable revenue growth beyond analyst expectations. Growing opportunities in personalized medicine and technology out-licensing could drive high-margin, recurring income streams and sustain long-term earnings growth.
View narrative
US$51.93
FV
83.0% undervalued
intrinsic discount
49.45%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Waldencast
AN
AnalystHighTarget
Consensus Narrative from 5 Analysts
Rising Global Wealth And Clean Beauty Will Fuel Growth
Key Takeaways Viral product launches and strong digital strategy could significantly accelerate revenue growth and enhance margins beyond current market expectations. Waldencast's asset-light, omnichannel model and early international expansion position it for strong premiumization, acquisition opportunities, and higher-than-expected long-term earnings growth.
View narrative
US$5.00
FV
65.4% undervalued
intrinsic discount
17.73%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Cryoport
AN
AnalystHighTarget
Consensus Narrative from 9 Analysts
Digitalization And Secular Trends Will Expand Biotech Cold Chain Services
Key Takeaways Cryoport's leading position in cell and gene therapy logistics, bolstered by global partnerships, drives strong market expansion and outsized long-term revenue potential. Operational scale, high-demand services, and technology integration are expected to drive significant margin gains and enhanced shareholder value.
View narrative
US$16.00
FV
46.2% undervalued
intrinsic discount
-4.20%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Cresco Labs
AN
AnalystHighTarget
Consensus Narrative from 7 Analysts
Rising Cannabis Legalization And Wellness Trends Will Fuel Expansion
Key Takeaways Cresco's operational discipline, vertical integration, and strategic exits position it to outperform peers in margin expansion and cash flow, supporting future aggressive growth. Strong positioning in high-growth markets and evolving premium product offerings enable Cresco to capitalize on consolidation and shifting consumer preferences for sustained leadership.
View narrative
CA$3.11
FV
57.6% undervalued
intrinsic discount
0.25%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
OmniAb
AN
AnalystHighTarget
Consensus Narrative from 7 Analysts
AI Integration And Global Biologics Demand Will Reshape Antibody Discovery
Key Takeaways OmniAb's expanding partner ecosystem and technology platform are set to drive accelerating milestone conversions, greater margin expansion, and multi-revenue growth well above consensus expectations. Integration of AI and diversification across therapeutic areas position OmniAb for sustained pipeline growth, higher recurring revenue, and faster profitability due to operational streamlining.
View narrative
US$11.00
FV
81.7% undervalued
intrinsic discount
58.03%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Ceres Power Holdings
AN
AnalystHighTarget
Consensus Narrative from 9 Analysts
APAC Net-Zero Mandates And Delta Partnerships Will Accelerate Hydrogen Adoption
Key Takeaways Accelerated commercialization and partnerships in APAC could drive earlier-than-expected growth, boosting royalties and market share in green hydrogen and power sectors. Unique technology advantages position Ceres for widespread adoption in next-generation infrastructure, supporting durable pricing power and sustained margin expansion.
View narrative
UK£3.20
FV
65.0% undervalued
intrinsic discount
11.73%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Value any company in seconds
Popular companies